Bristows Law Firm

Event Information Following on from our “new ERA of employment law” briefing session in April 2026, we are pleased to invite HR leaders, practitioners and in-house counsel to Part 2 of our analysis of the Employment Rights Act 2025 and other developments shaping the HR landscape. This session will provide practical guidance on what has changed, what is still to come, what it means for your business, and the steps you should be taking now to prepare.

Event Information Join us on Wednesday 7 October for our annual Data Protection Top 10 seminar, where we’ll count down the developments shaping data protection and digital regulation, and discuss what organisations should be doing now to stay ahead. Our team will cover the key legal, regulatory and commercial issues, from AI to international data transfers, enforcement trends, online safety, and the latest UK and EU developments, while looking ahead to what’s next.

The appointment strengthens the commercial disputes practice and builds on a litigation capability of more than 100 dispute resolution specialists, further strengthening Bristows’ expertise in large and complex mandates. Laura Steen, a leading expert in commercial disputes, will be joining the firm on 1 September 2026.

We are pleased to report our successful defence for Novartis AG in revocation proceedings brought by Accord Healthcare Limited in the English Patents Court. The case concerned Novartis’ European Patent (UK) No. 1 467 728 B1 and supplementary protection certificate SPC/GB16/025, which relate to Novartis’ Entresto® medicine.

One Nucleus convened this year’s ON Helix event at the Babraham Research Campus in Cambridge, attended by Bristows’ Jamie May and Erik Müürsepp, under the banner of “Disrupting Bio Innovation”. The conference explored the key trends currently driving change in the life sciences sector, with a particular focus on the breakthrough technologies, policies and business models that are shaping the therapeutic discovery and development landscape – which we set out to summarise in this article.

Event Information In-house teams are facing a growing number of AI-related requests, often with limited information to go on – whether that’s thin due diligence responses from vendors or an unclear picture from the business of how the tool will be used. At the same time, market norms around AI contracting continue to shift, and the technology itself keeps evolving, with more agentic solutions raising new legal challenges.

During July Bristows runs its annual work experience programme, the Joe Sako Summer Workshop, offering a bespoke experience for students who meet the PRIME criteria, are interested in a career in law and who may not otherwise have an opportunity to undertake work experience in a law firm. It is organised and hosted by Bristows in memory of Joe Sako, represented by our handstand logo, which celebrates Joe’s love of gymnastics.

Event Information Spanning 7 – 10 October 2026, the annual AIPPI World Congress offers excellent networking opportunities and an educational programme on current burning topics like UPC, experimental use and technological development and much more. Our patent litigation expert, Dominic Adair, will be attending. Why Attend?

Tom is a partner in Bristows’ Artificial Intelligence practice, advising clients across the AI ecosystem on procurement, governance and regulatory compliance. He advises both emerging AI businesses and established market leaders on the issues arising from AI adoption – from negotiating and structuring contracts with AI vendors, to designing governance frameworks that keep pace with a fast-moving regulatory landscape.

We are proud to report our successful defence for SOPHiA GENETICS of a PI application brought by Guardant Health Inc in the UPC Court of Appeal (2 July 2026; UPC_CoA_19/2026). Four complex patents relating to liquid biopsy and cancer diagnostics technology in the rapidly developing field of data-driven medicine had been successfully defended against at first instance in the Paris Local Division, with one of these further defended on appeal.